Where does Aquavit Pharmaceuticals, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Aquavit Pharmaceuticals, Inc. ranks #44,788 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Aquavit Pharmaceuticals, Inc. hold?

Aquavit Pharmaceuticals, Inc. holds 5 US utility patents granted between 2017 and 2024, spanning 11 technology areas.

What is Aquavit Pharmaceuticals, Inc.'s Innovation Score?

Aquavit Pharmaceuticals, Inc. has an Innovation Score of 33.7 out of 100 (45th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Aquavit Pharmaceuticals, Inc.'s patent grant rate increasing or decreasing?

Aquavit Pharmaceuticals, Inc.'s recent grant velocity is +50% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Aquavit Pharmaceuticals, Inc.'s patents?

Aquavit Pharmaceuticals, Inc.'s patents average 20.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Aquavit Pharmaceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Aquavit Pharmaceuticals, Inc.

Q: What technology areas does Aquavit Pharmaceuticals, Inc. focus on?

Aquavit Pharmaceuticals, Inc.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 4 patents, ranking #1,545 of 3,490 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 11 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Aquavit ranks #44,788 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 11 technology areas.

#44,788
of 49,997 US assignees by volume: 45th percentile
by Innovation Score (33.7/100): 20.8
avg claims per patent: +50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R44788 · US Corporation #44,788 · 5 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 5 grants
LOWER-Q #44,788/49,997
PHOTO-FINISH Apse
CPC-FOCUS A61M · 11 areas
INNOV-THIN 33.7/100
CLAIMS-DENSE 20.8 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Apse, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Aquavit’s 33.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (18%) Velocity 3.3 pts (10%) Breadth 11.7 pts (35%) Claim depth 12.5 pts (37%)

Qualcomm Incorporated · highest

85
Aquavit Pharmaceutic… · this assignee

34
3D Lighting… · lowest

7

What this shows Aquavit's Innovation Score is 33.7/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Aquavit?

Each dot is one of Aquavit’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Aquavit’s own 20.8 claims/patent is ABOVE the 14.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Aquavit vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Aquavit's grants concentrate

Aquavit Pharmaceuticals, Inc. is a focused PatentsView assignee: 11 CPC subclasses with 80% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2017. By volume, Aquavit sits between Apse, Inc. and ARC Medical Inc..

Aquavit's three-year grant acceleration

Aquavit Pharmaceuticals, Inc. shows 1 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Apse

5
APT

5
Aqua Conscience H…

5
Aquahydrex

5
AR Patents

5
AR

5
Aravive Biologics

5
ARC Medical

5
Aquavit Pharmaceu… ◀

5

What this shows Aquavit holds 5 patents at rank #44,592, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Aquavit

By rank, the assignees closest to #44,592 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Aquavit's primary technology class.

Aquavit's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 45th percentile higher than 45% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Aquavit Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	20.0%
2018	1	20.0%
2021	2	40.0%
2024	1	20.0%

Which technologies does Aquavit Pharmaceuticals, Inc. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 4

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 3

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 2

C12Y - Enzymes 1

G07F - Coin-freed OR Like Apparatus 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 1

B05B - Spraying APPARATUS; Atomising APPARATUS; Nozzles 1

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Aquavit Pharmaceuticals, Inc.'s patent record in context - here's where to go next.

Aquavit Pharmaceuticals, Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 80% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #44,788 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Aquavit Pharmaceuticals, Inc. against Apse, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.